VLDL, remnant cholesterol may help assess cardiovascular risk

Reuters Health - 30/11/2020 - Factors beyond low-density lipoprotein (LDL) cholesterol - i.e., very low-density lipoprotein (VLDL) or remnant cholesterol - may be important in assessing cardiovascular risk, suggest separate studies in the Journal of the American College of Cardiology. "LDL cholesterol is the main lipid measurement to guide clinical decisions," Dr. John Burnett of Royal Perth Hospital and Fiona Stanley Hospital Network told Reuters Health by email. "However, residual risk of atherosclerotic cardiovascular disease (ASCVD) remains even after LDL cholesterol is treated." "Triglycerides (TG) and/or the cholesterol content within TG-rich lipoproteins may contribute to residual lipid-related ASCVD risk," said Dr. Burnett, coauthor of an editorial commenting on both studies. In one study, Dr. Borge Nordestgaard of Copenhagen University Hospital and colleagues analyzed records of more than 25,000 individuals in the Copenhagen General Population Study ...

Please login to read the full text of the article.

If you have no account yet, please register now.

Posted on 30 November, 20204 December, 2020